Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Surojit Sur

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Spatial Regulation of CAR Signaling Enables Logic-Gated ActivityTushar D Nichakawade, Brian J Mog, Alexander H Pearlman, et al.
Science Translational Medicine|March 2, 2021
TCR β chain-directed bispecific antibodies for the treatment of T cell cancersSuman Paul, Alexander H Pearlman, Jacqueline Douglass, et al.
Nature|March 28, 2024
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancersTushar D Nichakawade, Jiaxin Ge, Brian J Mog, et al.
Nature Cancer|December 22, 2025
TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancersJiaxin Ge, Joshua Urban, Sarah R DiNapoli, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Spatial Regulation of CAR Signaling Enables Logic-Gated ActivityTushar D Nichakawade, Brian J Mog, Alexander H Pearlman, et al.
Science Translational Medicine|March 2, 2021
TCR β chain-directed bispecific antibodies for the treatment of T cell cancersSuman Paul, Alexander H Pearlman, Jacqueline Douglass, et al.
Nature|March 28, 2024
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancersTushar D Nichakawade, Jiaxin Ge, Brian J Mog, et al.
Nature Cancer|December 22, 2025
TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancersJiaxin Ge, Joshua Urban, Sarah R DiNapoli, et al.
Pageof 3